Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 31;9(2):50.
doi: 10.3390/antibiotics9020050.

Using Machine Learning Techniques to Aid Empirical Antibiotic Therapy Decisions in the Intensive Care Unit of a General Hospital in Greece

Affiliations

Using Machine Learning Techniques to Aid Empirical Antibiotic Therapy Decisions in the Intensive Care Unit of a General Hospital in Greece

Georgios Feretzakis et al. Antibiotics (Basel). .

Abstract

Hospital-acquired infections, particularly in the critical care setting, have become increasingly common during the last decade, with Gram-negative bacterial infections presenting the highest incidence among them. Multi-drug-resistant (MDR) Gram-negative infections are associated with high morbidity and mortality with significant direct and indirect costs resulting from long hospitalization due to antibiotic failure. Time is critical to identifying bacteria and their resistance to antibiotics due to the critical health status of patients in the intensive care unit (ICU). As common antibiotic resistance tests require more than 24 h after the sample is collected to determine sensitivity in specific antibiotics, we suggest applying machine learning (ML) techniques to assist the clinician in determining whether bacteria are resistant to individual antimicrobials by knowing only a sample's Gram stain, site of infection, and patient demographics. In our single center study, we compared the performance of eight machine learning algorithms to assess antibiotic susceptibility predictions. The demographic characteristics of the patients are considered for this study, as well as data from cultures and susceptibility testing. Applying machine learning algorithms to patient antimicrobial susceptibility data, readily available, solely from the Microbiology Laboratory without any of the patient's clinical data, even in resource-limited hospital settings, can provide informative antibiotic susceptibility predictions to aid clinicians in selecting appropriate empirical antibiotic therapy. These strategies, when used as a decision support tool, have the potential to improve empiric therapy selection and reduce the antimicrobial resistance burden.

Keywords: ICU; ML techniques; antibiotic resistance; antimicrobial resistance; artificial intelligence; intensive care unit; machine learning; prediction.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Gandra S., Barter D.M., Laxminarayan R. Economic burden of antibiotic resistance: How much do we really know? Clin. Microbiol. Infect. 2014;20:973–979. doi: 10.1111/1469-0691.12798. - DOI - PubMed
    1. Cassini A., Högberg L.D., Plachouras D., Quattrocchi A., Hoxha A., Simonsen G.S., Colomb-Cotinat M., Kretzschmar M.E., Devleesschauwer B., Cecchini M., et al. Burden of AMR Collaborative Group Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis. Lancet Infect. Dis. 2019;19:56–66. doi: 10.1016/S1473-3099(18)30605-4. - DOI - PMC - PubMed
    1. Potron A., Poirel L., Nordmann P. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology. Int. J. Antimicrob. Agents. 2015;45:568–585. doi: 10.1016/j.ijantimicag.2015.03.001. - DOI - PubMed
    1. European Centre for Disease Prevention and Control . Antimicrobial Resistance Surveillance in Europe 2015. ECDC; Stockholm, Sweden: 2017. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)
    1. Albiger B., Glasner C., Struelens M.J., Grundmann H., Monnet D.L. European Survey of Carbapenemase-Producing Enterobacteriaceae working group Carbapenemase-producing Enterobacteriaceae in Europe: Assessment by national experts from 38 countries. Euro Surveill. 2015;20:30062. doi: 10.2807/1560-7917.ES.2015.20.45.30062. - DOI - PubMed